Oribalt

What Oribalt does

Oribalt Group is a pharmaceutical logistics and wholesale distribution company operating across the three Baltic states of Estonia, Latvia, and Lithuania, with its headquarters in Mārupe, Latvia. The company provides an integrated suite of services including pharmaceutical wholesale distribution, warehousing and transportation, cold chain logistics, hospital and public tender management, GMP-compliant repackaging and labelling, clinical trial material logistics, marketing services for own and third-party brands, and pharmacy operations comprising two physical pharmacies in Riga and the InternetAptieka online pharmacy in Latvia. Oribalt serves pharmacies, healthcare centres, hospitals, dentists, pharmaceutical manufacturers, and other wholesale companies in the Baltic region, distributing products sourced from more than 200 producers worldwide.

The company operates from three main facilities: AS Oribalt Tallinn (Estonia), SIA Oribalt Rīga (Latvia regional headquarters), and Oribalt Vilnius UAB (Lithuania, a 6,500 sq.m purpose-built logistics centre with 8,500 pallet storage capacity constructed in 2020-2021 for EUR 4.8 million). Core technology consists of the iScala ERP system validated to GMP and GDP standards, electronic temperature monitoring, validated refrigerators and thermo boxes, and specially equipped temperature-controlled vehicles. The company holds EU GDP, GSP, and GMP compliance certifications, with each subsidiary operating an independent quality assurance structure.

Oribalt's business model is B2B-led with a sales-driven go-to-market motion. Direct sales teams visit pharmacies, supermarkets, and doctors, while the company also participates in public, municipal, and hospital tenders in cooperation with pharmaceutical manufacturers. Revenue is generated from transactional wholesale distribution margins, professional services fees for logistics, tender management, and repackaging, and consumer retail sales through physical and online pharmacies. The company was established in 2017 following the acquisition of Baltic operations from Finland's Oriola Group, continuing business operations that began in the early 1990s.

Name

Oribalt

Legal name

Oribalt Group

Website

https://oribalt.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Oribalt Group provides pharmaceutical logistics, wholesale distribution, cold chain management, repackaging, clinical trial logistics, and pharmacy retail services across Estonia, Latvia, and Lithuania, serving pharmacies, hospitals, healthcare providers, and pharmaceutical manufacturers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution and Logistics

NAICS

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

akta.pro secondary industry

Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)

Keywords

• Pharmaceutical logistics services
• Pharmaceutical wholesale distribution
• Cold chain management
• Hospital tender services
• Clinical trial logistics

Headquarters

HQ city

Marupe

HQ country

Latvia

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Wholesale Distribution: Oribalt Group companies in Tallinn, Riga, and Vilnius distribute pharmaceutical and healthcare products to pharmacies, healthcare centres, hospitals, and dentists as pharmaceutical wholesalers. They deal with products from more than 200 producers worldwide and offer services based on customer needs according to international ethical standards.
2. Pharmaceutical Logistics Services: Provides warehousing, distribution, transportation, direct delivery models, cold chain logistics, direct deliveries to patients, labelling, and other pre-wholesale services adapted to customer needs across the Baltic region.
3. Hospital Tender Services: Provides tender services by gathering information about announced public, municipal, and hospital tenders, participating in tenders in cooperation with pharmaceutical manufacturers, and managing supply planning, inventory control, and contractual deliveries.
4. Repackaging/Labelling Services: Provides labelling of medicinal products in accordance with Good Manufacturing Practice standards and Latvian law, including pasting of manufacturer-approved labels and insertion of patient leaflets.
5. Clinical Trials Logistics: Manages the entire logistic chain of clinical trial materials and medicines including cold and ambient temperature-controlled deliveries, and provides expertise in receiving, storing, and shipping comparator compounds.
6. Marketing Services: Provides traded goods including food supplements, vitamins, skincare products, and gluten-free products. Sales teams visit pharmacies, supermarkets, and doctors. Also handles sales and marketing of Oribalt Group's own brands.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels4 records

Core offering

Oribalt is a pharmaceutical logistics and wholesale distribution company serving the Baltic states from warehouses in Tallinn (Estonia), Riga (Latvia), and Vilnius (Lithuania). The company distributes pharmaceutical and healthcare products from more than 200 producers worldwide to pharmacies, healthcare centres, hospitals, and dentists, and provides integrated services including warehousing, transportation, temperature-controlled cold chain logistics, hospital tender participation, GMP-compliant repackaging, clinical trial material logistics, and marketing services.

Product overview

Oribalt is a pharmaceutical logistics and wholesale company operating in the Baltic region (Estonia, Latvia, Lithuania). The company offers an integrated portfolio of services: Logistics (warehousing, distribution, transportation, cold chain), Wholesale (pharmaceutical distribution to pharmacies and hospitals), Tenders (hospital procurement services), Repackaging (GMP-compliant labeling), Clinical Trials (logistics for trial materials), Marketing Services (sales and trading), and Pharmacies (InternetAptieka online pharmacy and physical pharmacies in Riga). Established in 2017 after acquiring Baltic operations from Oriola Group, the company traces its heritage to the early 1990s under the Oriola name.

Differentiator

Problem solved

Functional benefit

Brands

• InternetAptieka: Leading online pharmacy in Latvia, part of Oribalt group, offering wide range of products with fair price and free fast delivery

Products and services

• Pharmaceutical Logistics Services
• Pharmaceutical Wholesale Distribution
• Hospital Tender Services
• Repackaging Services
• Clinical Trials Logistics
• Marketing Services
• Pharmacy Operations (Panpharmacy and InternetAptieka)

Quantifiable outcome

• Storage capacity doubled to 8,500 pallet places in Lithuania with new facilities
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Regional players

• Euroapotheca: Lithuanian-headquartered pharmacy retail and wholesale group operating across the Baltic states. Comparable as a regional pharmacy and pharma distribution platform intersecting with Oribalt's wholesale and InternetAptieka pharmacy businesses.
• Sopharma Trading: Bulgarian-headquartered pharmaceutical wholesaler serving Eastern and Southeastern European markets. Comparable as a regional pharma wholesaler operating in adjacent Eastern European geographies with similar product portfolios and customer types.

Direct peers

• Tamro (Phoenix Group): Pharmaceutical wholesale distributor operating across the Baltic states and other European markets as part of Phoenix Group. Directly competes with Oribalt in Estonia, Latvia, and Lithuania across wholesale, distribution, and pharmacy services.
• Magnum Medical: Estonian-based pharmaceutical and medical device wholesaler serving pharmacies, hospitals, and healthcare providers in the Baltic region. Overlaps with Oribalt on pharmaceutical wholesale distribution in Estonia and increasingly across the Baltics.
• Oriola Corporation: Former parent of Oribalt's Baltic operations, now focused on pharmaceutical distribution and retail pharmacies in Finland and Sweden. Operates the same wholesale-plus-pharmacy model and was Oribalt's structural predecessor.

Broad incumbents

• McKesson: Global pharmaceutical wholesaler and healthcare services company. Comparable to Oribalt as a wholesale/distribution peer at the category level, with substantially greater scale and geographic reach.
• BENU Apotheek: European pharmacy retail chain (part of Phoenix Group) operating across multiple European countries. Comparable to Oribalt's downstream pharmacy/retail layer (physical pharmacies and InternetAptieka).
• Cencora: Global pharmaceutical distribution and services company (formerly AmerisourceBergen). Sets the broader competitive reference point for pharmaceutical distribution scale, logistics, and manufacturer services globally.
• Phoenix Group: Pan-European pharmaceutical distribution and pharmacy retail group headquartered in Germany; parent of Tamro. Competes with Oribalt at the regional level via Tamro and represents the most direct large-scale incumbent in the Baltic wholesale market.
• Mediq: European distributor of medical devices, pharmaceuticals, and related healthcare supplies to hospitals, pharmacies, and care providers. Comparable to Oribalt on the medical/pharmaceutical supply distribution side of the business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/oribalt

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oribalt